文献速递胸部技术与安全CTPET

使用深度卷积神经网络对淋巴瘤和肺癌患者的18F-FDG PET/CT摄取进行分类

18F-FDG PET/CT Uptake Classification in Lymphoma and Lung Cancer by Using Deep Convolutional Neural Networks.
PubMed 文献 · Radiology · 2019-12-10

这项回顾性单中心研究纳入了2011年8月至2013年8月间的629例肺癌或淋巴瘤患者,以两名核医学专家手动勾画并分类的18F-FDG摄取灶为参考标准,开发卷积神经网络(CNN)检测摄取灶、预测解剖位置并判定专家分类。在测试集123例患者(10782个病灶)中,CNN判定可疑肿瘤/转移灶与非可疑灶的AUC在联合PET/CT及MIP等输入下可达0.98–0.99,解剖定位准确率在身体部位为96.4%、器官区域为86.9%、亚区域为81.4%。

要点

  • CNN以专家判读为参考,联合PET与CT信息可高AUC区分可疑与非可疑18F-FDG摄取灶。
  • 测试集AUC:CT单独0.78,PET单独0.97,PET/CT 0.98,PET/CT MIP 0.98,PET/CT MIP图谱0.99。
  • CNN解剖定位准确率:身体部位96.4%、器官区域86.9%、亚区域81.4%。

核心结论

  • 全自动CNN对肺癌和淋巴瘤患者18F-FDG PET摄取灶进行解剖定位及可疑/非可疑分类是可行的,联合CT与PET图像时诊断性能高。

研究设计与样本

  • 回顾性分析连续纳入的单中心肺癌或淋巴瘤患者,时间为2011年8月至2013年8月,共629例(平均年龄52.2岁±20.4,394名男性),其中肺癌302例、淋巴瘤327例。
  • 由两名核医学专家手动勾画18F-FDG摄取增高灶、指定解剖位置并分类为可疑肿瘤/转移或非可疑,以此作为参考标准开发CNN。
  • 检查分为独立训练集(60%)、验证集(20%)和测试集(20%);测试集123例患者、10782个病灶。

诊断标准与关键数值

  • 测试集中CNN判定可疑癌症与非可疑高代谢18F-FDG PET/CT灶的AUC:CT单独0.78(95%CI:0.72,0.83);18F-FDG PET单独0.97(95%CI:0.97,0.98);18F-FDG PET/CT 0.98(95%CI:0.97,0.99);18F-FDG PET/CT MIP 0.98(95%CI:0.98,0.99);18F-FDG PET/CT MIP图谱0.99(95%CI:0.98,1.00)。
  • 联合18F-FDG PET与CT信息改善了总体分类准确率(AUC 0.975 vs 0.981,P < .001)。
  • CNN解剖定位准确率:身体部位2543/2639(96.4%;95%CI:95.5%,97.1%);区域(即器官)2292/2639(86.9%;95%CI:85.3%,88.5%);亚区域2149/2639(81.4%;95%CI:79.3%–83.5%)。

临床应用与阅片要点

  • 原文结论认为,联合CT与PET图像时CNN对肺癌和淋巴瘤18F-FDG PET摄取灶的解剖定位与可疑/非可疑分类是可行的且诊断性能高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Fluorine 18 (18F)-fluorodeoxyglucose (FDG) PET/CT is a routine tool for staging patients with lymphoma and lung cancer. Purpose To evaluate configurations of deep convolutional neural networks (CNNs) to localize and classify uptake patterns of whole-body 18F-FDG PET/CT images in patients with lung cancer and lymphoma. Materials and Methods This was a retrospective analysis of consecutive patients with lung cancer or lymphoma referred to a single center from August 2011 to August 2013. Two nuclear medicine experts manually delineated foci with increased 18F-FDG uptake, specified the anatomic location, and classified these findings as suspicious for tumor or metastasis or nonsuspicious. By using these expert readings as the reference standard, a CNN was developed to detect foci positive for 18F-FDG uptake, predict the anatomic location, and determine the expert classification. Examinations were divided into independent training (60%), validation (20%), and test (20%) subsets. Results This study included 629 patients (mean age, 52.2 years ± 20.4 [standard deviation]; 394 men). There were 302 patients with lung cancer and 327 patients with lymphoma. For the test set (123 patients; 10 782 foci), the CNN areas under the receiver operating characteristic curve (AUCs) for determining hypermetabolic 18F-FDG PET/CT foci that were suspicious for cancer versus nonsuspicious by using the five input features were as follows: CT alone, 0.78 (95% confidence interval [CI]: 0.72, 0.83); 18F-FDG PET alone, 0.97 (95% CI: 0.97, 0.98); 18F-FDG PET/CT, 0.98 (95% CI: 0.97, 0.99); 18F-FDG PET/CT maximum intensity projection (MIP), 0.98 (95% CI: 0.98, 0.99); and 18F-FDG PET/CT MIP atlas, 0.99 (95% CI: 0.98, 1.00). The combination of 18F-FDG PET and CT information improved overall classification accuracy (AUC, 0.975 vs 0.981, respectively; P < .001). Anatomic localization accuracy of the CNN was 2543 of 2639 (96.4%; 95% CI: 95.5%, 97.1%) for body part, 2292 of 2639 (86.9%; 95% CI: 85.3%, 88.5%) for region (ie, organ), and 2149 of 2639 (81.4%; 95% CI: 79.3%-83.5%) for subregion. Conclusion The fully automated anatomic localization and classification of fluorine 18-fluorodeoxyglucose PET uptake patterns in foci suspicious and nonsuspicious for cancer in patients with lung cancer and lymphoma by using a convolutional neural network is feasible and achieves high diagnostic performance when both CT and PET images are used. © RSNA, 2019 Online supplemental material is available for this article. See also the editorial by Froelich and Salavati in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Sibille L, Seifert R, Avramovic N, et al. 18F-FDG PET/CT Uptake Classification in Lymphoma and Lung Cancer by Using Deep Convolutional Neural Networks. Radiology. 2019. PMID: 31821122. doi:10.1148/radiol.2019191114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。